• SENSEX 73,709.69
    -143.21 (--0.19%)
  • BANKNIFTY 54,976.90
    -511.20 (--0.92%)
  • Max Healthcare
    811.50 811.50(%)
  • L&T Technology
    4,140.50 4,746.95(%)
  • Bajaj Finance
    919.00 788.40(%)
  • NSE
    1,705.00 1,705.00(%)
  • Reliance Industries
    1,234.60 1,611.20(%)
  • TCS
    2,533.10 3,336.70(%)
  • PC Jeweller
    19.14 19.14(%)
  • Cupid
    343.65 369.70(%)
  • HD Fire Protect
    338.00 338.00(%)
  • Infosys
    1,171.00 1,727.85(%)
  • ZF Commercial
    2,073.00 2,053.38(%)
  • Aditya Infotech
    3,879.70 1,301.10(%)
  • HDFC Bank
    698.35 682.00(%)
  • Fractal Analyt.
    828.00 1,119.60(%)
  • SS Retail
    724.90 888.00(%)
  • ICICI Bank
    1,409.50 1,479.90(%)
  • APL Apollo Tubes
    2,052.10 1,691.05(%)
  • Sun Pharma.Inds.
    1,721.70 1,583.60(%)
  • Netweb Technol.
    4,575.95 2,942.45(%)
  • CreditAcc. Gram.
    1,129.35 1,112.90(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gland Pharma Ltd Pharmaceuticals - Indian - Formulations

  • MNC Associate
  • BSE Code : 14546.0
  • ISIN : INE068V01023
2,935.00 -85 (-2.81%)
  • As on 21 Oct 2026 (EOD)

  • Today’s Low

    2,839.60

  • Today’s High

    3,028.30

  • Open

    3,005.10

  • Perv Close

    3,019.80

  • 52W Low

    1,573.60

  • 52W High

    3,171.00

Key Indicators

  • P/E(TTM)

    34.16

  • Mar.Cap (₹Cr.)

    48,430.69

  • Div & Yield %

    0.68

  • Book Value(₹)

    655.11

  • Debt-Equity Ratio

    -2.81

  • AGM Date

    21-Oct-2026

  • EPS

    85.60

  • P/E Ratio

    34.16

Financials Ratios

  • Debt-Equity Ratio

    0.02

  • Mar.Cap (₹Cr.)

    48,430.69

  • RONW (%)

    9.26

  • ROCE (%)

    13.44

Score Board

  • Equity (₹ in Cr.)

    16.50

  • BV (₹)

    655.10

  • Sales( ₹ in Cr.)

    4,552.09

  • NP (in Cr.)

    1,315.23

  • NP Var(%)

    21.0

  • Div%

    2000.0

  • CPS (₹)

    90.40

  • EPS (₹)

    79.70

  • Traded Value (₹ in Lakhs)

    48,254.12

  • 52 Week High

    3,171.00

  • 52 Week Low

    1,573.60

  • Price BSE

    2924.0

  • Price NSE

    2,935.00

  • Market Capital( in Cr.)

    48,254.12

  • P/C Ratio

    32.40

  • P/E Ratio

    36.70

  • Price Vs.BV

    79.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 4,552.09 4,116.15 4,167.43 3,616.53 4,400.71 3,462.88
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 4,552.09 4,116.15 4,167.43 3,616.53 4,400.71 3,462.88
Other Income 303.90 215.08 166.67 240.46 223.94 134.78
Stock Adjustments 6.67 -130.25 -87.43 46.92 -36.69 273.49
Total Income 4,862.66 4,200.98 4,246.67 3,903.91 4,587.96 3,871.15
EXPENDITURE :            
Raw Materials 1,801.82 1,600.35 1,732.88 1,732.34 2,072.53 1,765.36
Power and Fuel Cost 122.38 120.38 117.20 124.84 95.05 74.59
Employee Cost 528.82 439.02 409.95 399.70 338.57 311.36
Other Manufacturing Expenses 209.14 188.89 186.92 153.84 137.19 130.84
Selling and Administration Expenses 197.33 155.54 175.97 189.65 177.43 128.44
Miscellaneous Expenses 60.53 39.10 48.31 100.99 32.61 23.51
Employee Benefit Expenses 528.82 439.02 409.95 399.70 338.57 311.36
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,920.02 2,543.29 2,671.22 2,701.35 2,853.38 2,434.10
Operating Profit 1,942.62 1,657.70 1,575.44 1,202.55 1,734.58 1,437.04
Interest 18.07 22.84 7.84 7.41 5.24 3.41
Gross Profit 1,924.55 1,634.86 1,567.60 1,195.14 1,729.34 1,433.63
Depreciation 176.24 169.27 162.11 146.74 110.30 98.78
Profit Before Tax 1,748.31 1,465.59 1,405.49 1,048.40 1,619.04 1,334.85
Current Tax 452.59 366.71 337.49 275.38 392.88 337.73
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -3.83 9.12 24.68 -2.80 14.01 0.12
Reported Net Profit 1,299.55 1,089.75 1,043.33 775.83 1,212.16 997.01
Extraordinary Items -15.68 1.64 -0.39 -39.55 3.22 0.02
Adjusted Net Profit 1,315.23 1,088.11 1,043.72 815.38 1,208.94 996.99
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 7,814.28 7,054.03 6,010.70 5,234.88 4,022.72 3,025.72
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 296.56 329.50 0.00 0.00 0.00 0.00
P & L Balance carried down 8,817.27 7,814.28 7,054.03 6,010.70 5,234.88 4,022.72
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 2,000.00 1,800.00 2,000.00 0.00 0.00 0.00
Dividend Per Share(Rs) 20.00 18.00 20.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 78.88 66.14 63.34 47.11 73.78 60.95
Earnings Per Share(Adj)-Unit Curr 78.88 66.14 63.34 47.11 73.78 60.95
Book Value 656.11 592.08 546.13 482.90 435.68 360.86
Book Value(Adj)-Unit Curr 656.11 592.08 546.13 482.90 435.68 360.86

Shareholding Pattern

  • Promoter Group

    45.75%

  • Public Share Holding

    54.25%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 75,496,934 45.75 75,496,934 5
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 75,496,934 45.75 75,496,934 5
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 17,155 0.01 17,155 2
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 17,097,144 10.36 17,097,144 266
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4,011,284 2.43 4,011,284 12
Mutual Funds / UTI 48,714,045 29.52 48,714,045 31
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,081,520 1.26 2,081,520 44
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 71,921,148 43.59 71,921,148 355
2] Non Institution
Bodies Corporate 8,788,012 5.33 2,788,012 1,100
Clearing Members 38,943 0.02 38,943 36
Directors of their Relatives 77,887 0.05 77,887 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 506,989 0.31 506,989 3,827
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 272,050 0.16 272,050 2,204
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,000,000 0.61 1,000,000 1
Individuals holding nominal share capital up to Rs. 1 lakh 6,637,293 4.02 6,637,293 117,994
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 117,969 0.07 117,969 9
Others 27,026 0.02 27,026 1
Sub Total 17,592,772 10.66 11,592,772 125,307
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 165,010,854 100.00 159,010,854 125,667

Company Background

Gland Pharma LtdPharmaceuticals - Indian - Formulations

  • Gland Pharma Ltd
  • BSE Code : 14546.0
  • ISIN : INE068V01023

  • Incorporation Year

    1978

  • Registered Office

    Sy No 143-148 150&151 Nr Gandi
    X Roads D P Pally Dundigal, Hyderabad,
    Telangana-500043

  • Telephone

    91-40-30510999

  • FAX

    91-40-30510800

  • Chairman

    SRINIVAS SADU

  • Managing Director

  • Company Secretary

  • Auditor

    Deloitte Haskins & Sells

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Gland Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Gland Pharma 2,924.30 4,855.99 4,552.09 34.60 17.11
Abbott India 25,744.40 7,217.19 6,929.05 33.88 43.78
Astrazeneca Phar 6,076.90 2,304.07 2,275.58 89.56 27.86
Glaxosmi. Pharma 2,463.75 3,932.76 3,790.20 39.36 58.17
Novartis India 1,768.90 393.10 354.33 44.67 15.94
Cipla 1,313.80 20,102.60 18,979.95 34.53 13.88
Bliss GVS Pharma 609.80 773.53 729.81 56.67 12.51
Amrutanjan Healt 495.10 520.13 502.55 26.52 24.16
Fermenta Biotec. 465.60 474.15 450.25 21.74 18.77
Guj. Themis Bio. 351.30 168.25 165.82 93.93 18.05
Ambalal Sarabhai 36.94 19.52 3.94 68.41 6.77